Boston Scientific (BSX) Income towards Parent Company (2009 - 2026)

Boston Scientific has disclosed Income towards Parent Company across 18 years of filings, most recently posting $1.3 billion for Q1 2026.

• Income towards Parent Company for Q1 2026 came in at $1.3 billion, up 99.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 billion (up 75.75% YoY), and the FY2025 annual result was $2.9 billion, up 56.66% from the prior year.
• Income towards Parent Company came in at $1.3 billion for Q1 2026 at Boston Scientific, up from $670.0 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $1.3 billion in Q1 2026 to a low of $111.0 million in Q1 2022.
• The 5-year median for Income towards Parent Company is $493.0 million (2024), against an average of $492.3 million.
• Across the five-year window, Income towards Parent Company tumbled 67.45% in 2022 and surged 257.45% in 2023, its largest moves.
• Boston Scientific's Income towards Parent Company stood at $141.0 million in 2022, then soared by 257.45% to $504.0 million in 2023, then advanced by 11.51% to $562.0 million in 2024, then grew by 19.22% to $670.0 million in 2025, then surged by 99.7% to $1.3 billion in 2026.
• The last three Income towards Parent Company figures came in at $1.3 billion (Q1 2026), $670.0 million (Q4 2025), and $756.0 million (Q3 2025), per Business Quant data.